Aniket Bankar, University of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?
Clinical lymphoma, myeloma & leukemia · 2026
Identifying Risk Factors and Outcome for CNS Involvement in AML.
Clinical lymphoma, myeloma & leukemia · 2025
Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis.
Blood cancer journal · 2025

All 8 publications

Latest funding

GLP-1 Receptor Agonists as a Preventive Strategy for Clonal Hematopoiesis-Driven Hematologic Cancers
CIHR · 2025 · Co-investigator

All 1 grants and awards

8 publications.

01

What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?

Rajendra A, Smith E, Atenafu EG, Bankar A, Chan S, Davidson M, Gupta V, Minden MD, Perusini MA, Richard-Carpentier G, Schimmer A, Schuh AC, Sibai H, Yee K, Maze D

Clinical lymphoma, myeloma & leukemia2026

DOI: 10.1016/j.clml.2025.10.016 PMID: 41238480

02

Identifying Risk Factors and Outcome for CNS Involvement in AML.

Seki JT, Daher-Reyes GS, Atenafu EG, Sibai J, Bankar A, Young T, Chan S, Yee K, Gupta V, Minden MD, Maze D, Schuh A, Schimmer A, Sibai H

Clinical lymphoma, myeloma & leukemia20253 citations

DOI: 10.1016/j.clml.2025.06.010 PMID: 40744760

03

Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis.

Rajendra A, Smith E, Perusini MA, Tang K, Atenafu EG, Bankar A, Chan S, Davidson MB, Gupta V, Maze D, Minden MD, Richard-Carpentier G, Schimmer AD, Schuh AC, Yee K, Sibai H

Blood cancer journal20251 citationsOpen Access

DOI: 10.1038/s41408-025-01353-2 PMID: 40854875

04

Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention.

Bankar A

Haematologica2025First author

DOI: 10.3324/haematol.2025.288227 PMID: 40820796

05

Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study

England JT, Szuber N, Sirhan S, Dunne T, Cerquozzi S, Hill M, Villeneuve PJA, Ho JM, Sadikovic B, Bhai P

Leukemia202416 citations

DOI: 10.1038/s41375-024-02155-4

06

Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AML.

Smith E, Atenafu EG, Bankar A, Chan S, Davidson M, Gupta V, Minden MD, Richard-Carpentier G, Schimmer A, Schuh AC, Sibai H, Yee K, Maze D

European journal of haematology2024Open Access

DOI: 10.1111/ejh.14283 PMID: 39113600

07

Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first‐line JAK‐inhibitor

James T. England, Eshetu G. Atenafu, James A. Kennedy, Burhan Goraya, Verna Cheung, Taylor Nye, Karine Gauthier, Marta Beata Davidson, Aniket Bankar, Hassan Abdulmaoula Sibai, Dawn C. Maze, Auro Viswabandya, Vikas K Gupta

American Journal of Hematology20235 citationsOpen Access

DOI: 10.1002/ajh.26890 PMID: 36814403

08

Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis.

Smith E, Huang J, Viswabandya A, Maze D, Malik S, Cheung V, Siddiq N, Claudio J, Arruda A, Kennedy J, Bankar A, Law AD, Lam W, Michelis FV, Kim D, Lipton J, Kumar R, Mattsson J, McNamara C, Sibai H, Xu W, Gupta V

Transplantation and cellular therapy20218 citationsOpen Access

DOI: 10.1016/j.jtct.2021.03.027 PMID: 33798769

GLP-1 Receptor Agonists as a Preventive Strategy for Clonal Hematopoiesis-Driven Hematologic Cancers

Co-investigatorCIHR2025Team Grant: Bringing Biology to Cancer Prevention - General Pool

Principal investigators: Chan, Steven M; Drucker, Daniel J; Xie, Stephanie Z

Keywords: Cancer Prevention; Clonal Fitness; Clonal Hematopoiesis; Diabetes; Glp1 Receptor Agonist; Hematological Malignancies; Hematopoietic Stem Cells; Inflammation; Metabolism; Myeloid Neoplasms

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Aaron Schimmer and Mark Minden: 296 shared papers
Mark Minden and Steven Chan: 162 shared papers
Aaron Schimmer and Steven Chan: 92 shared papers
Aaron Schimmer and Dawn Maze: 77 shared papers
Steven Chan and Dawn Maze: 74 shared papers
Jonas Mattsson and Rajat Kumar: 70 shared papers
Jonas Mattsson and Auro Viswabandya: 67 shared papers
Mark Minden and Dawn Maze: 66 shared papers
Rajat Kumar and Auro Viswabandya: 66 shared papers
Auro Viswabandya and Wilson Lam: 55 shared papers
Jonas Mattsson and Wilson Lam: 54 shared papers
Rajat Kumar and Wilson Lam: 54 shared papers
Mark Minden and Vikas Gupta: 26 shared papers
Aaron Schimmer and Vikas Gupta: 25 shared papers
Vikas Gupta and Dawn Maze: 22 shared papers
Maria Perusini and Dawn Maze: 21 shared papers
Hassan Sibai and Dawn Maze: 20 shared papers
Aaron Schimmer and Maria Perusini: 19 shared papers
Steven Chan and Maria Perusini: 19 shared papers
Hassan Sibai and Vikas Gupta: 19 shared papers
Karen Yee and Vikas Gupta: 12 shared papers
Aaron Schimmer and Karen Yee: 11 shared papers
Aaron Schimmer and Hassan Sibai: 10 shared papers
Mark Minden and Karen Yee: 9 shared papers
Aniket Bankar and Hassan Sibai: 7 shared papers
Aniket Bankar and Vikas Gupta: 7 shared papers
Aniket Bankar and Dawn Maze: 7 shared papers
Christopher Hillis and Dawn Maze: 6 shared papers
Aaron Schimmer and Andre Schuh: 6 shared papers
Karen Yee and Andre Schuh: 6 shared papers
Auro Viswabandya and Dennis Kim: 6 shared papers
Vikas Gupta and Andre Schuh: 6 shared papers
Vikas Gupta and Dennis Kim: 6 shared papers
Wei Xu and James Kennedy: 5 shared papers
Jonas Mattsson and Dennis Kim: 5 shared papers
Aaron Schimmer and Aniket Bankar: 4 shared papers
Mark Minden and Aniket Bankar: 4 shared papers
Steven Chan and Aniket Bankar: 4 shared papers
Karen Yee and Aniket Bankar: 4 shared papers
Christopher Hillis and Vikas Gupta: 3 shared papers
Aaron Schimmer and Guillaume Richard-Carpentier: 3 shared papers
Wei Xu and Auro Viswabandya: 3 shared papers
Wei Xu and Hassan Sibai: 3 shared papers
Mark Minden and Guillaume Richard-Carpentier: 3 shared papers
Steven Chan and Guillaume Richard-Carpentier: 3 shared papers
Aniket Bankar and Guillaume Richard-Carpentier: 3 shared papers
Christopher Hillis and Bekim Sadikovic: 2 shared papers
Christopher Hillis and Natasha Szuber: 2 shared papers
Aaron Schimmer and Marta Davidson: 2 shared papers
Mark Minden and Marta Davidson: 2 shared papers
Steven Chan and Marta Davidson: 2 shared papers
Maria Perusini and Aniket Bankar: 2 shared papers
Aniket Bankar and Auro Viswabandya: 2 shared papers
Aniket Bankar and Marta Davidson: 2 shared papers
Vikas Gupta and Natasha Szuber: 2 shared papers
Dawn Maze and Natasha Szuber: 2 shared papers
Christopher Hillis and Aniket Bankar: 1 shared paper
Wei Xu and Aniket Bankar: 1 shared paper
Jonas Mattsson and James Kennedy: 1 shared paper
Jonas Mattsson and Aniket Bankar: 1 shared paper
Bekim Sadikovic and Aniket Bankar: 1 shared paper
Bekim Sadikovic and Hassan Sibai: 1 shared paper
James Kennedy and Rajat Kumar: 1 shared paper
James Kennedy and Aniket Bankar: 1 shared paper
Rajat Kumar and Aniket Bankar: 1 shared paper
Aniket Bankar and Andre Schuh: 1 shared paper
Aniket Bankar and Wilson Lam: 1 shared paper
Aniket Bankar and Dennis Kim: 1 shared paper
Aniket Bankar and Natasha Szuber: 1 shared paper

Department of Medicine
Department of Medical Biophysics
Department of Pathology and Laboratory Medicine
Department of Oncology
Institute of Medical Science
Department of Psychiatry
Département de médecine
Other

1 shared papers, latest 2024

James Kennedy

Department of Psychiatry

1 shared papers, latest 2021

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Bankar, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]